Trimebutine
Product Specifications
CAS Number
39133-31-8
Target
Apoptosis|||Opioid Receptor|||Potassium Channel|||Calcium Channel|||IRAK|||NF-?B|||Akt|||JNK|||ERK|||TLR
Related Pathways
NF-?B|||GPCR/G Protein|||Immunology/Inflammation|||Membrane transporter/Ion channel|||MAPK|||Endocrinology/Hormones|||Cytoskeletal Signaling|||Apoptosis|||Metabolism|||PI3K/Akt/mTOR signaling|||Neuroscience
Purity
0.9986
Bioactivity
Trimebutine (Mebutin) is a spasmolytic agent that regulates intestinal and colonic motility and relieves abdominal pain with antimuscarinic and weak mu-opioid agonist effects. It is marketed for the treatment of irritable bowel syndrome (IBS) and lower gastrointestinal tract motility disorders, with IBS being one of the most common multifactorial GI disorders. It is used to restore normal bowel function and is commonly present in pharmaceutical mixtures as trimebutine maleate salt form. Trimebutine is not an FDA-Approved/Clinical drug, but it is available in Canada and several other international countries.
Smiles
C(COC(=O)C1=CC(OC)=C(OC)C(OC)=C1)(N(C)C)(CC)C2=CC=CC=C2
Molecular Formula
C22H29NO5
Molecular Weight
387.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
